Iniciar Sessão

Notícias e actividades

[EasyDNNnews:IfExists:Image]

[EasyDNNnews:EndIf:Image]

[EasyDNNnews:SubTitle]

[EasyDNNnews:IfExists:Image]

[EasyDNNnews:EndIf:Image]

[EasyDNNnews:SubTitle]

[EasyDNNnews:IfExists:Image]

[EasyDNNnews:EndIf:Image]

[EasyDNNnews:SubTitle]

[EasyDNNnews:IfExists:Image]

[EasyDNNnews:EndIf:Image]

[EasyDNNnews:SubTitle]

Consulte a notícia para saber quais os períodos de encerramento nos serviços sub-regionais.

[EasyDNNnews:IfExists:Image]

[EasyDNNnews:EndIf:Image]

[EasyDNNnews:SubTitle]

The LancetThe pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might be curtailed by vaccination. We assessed the safety, reactogenicity, and immunogenicity of a viral vectored coronavirus vaccine that expresses the spike...

[EasyDNNnews:IfExists:Image]

[EasyDNNnews:EndIf:Image]

[EasyDNNnews:Title]

[EasyDNNnews:SubTitle]

Acta Médica PortuguesaIn Portugal, as in many other countries worldwide, medical doctors are rarely allowed to have protected research time. As a result, almost all research conducted by physicians is done afterhours, thus potentially...

[EasyDNNnews:IfExists:Image]

[EasyDNNnews:EndIf:Image]

[EasyDNNnews:Title]

[EasyDNNnews:SubTitle]

The LancetThis is the first randomised controlled trial for assessment of the immunogenicity and safety of a candidate non-replicating adenovirus type-5 (Ad5)-vectored COVID-19 vaccine, aiming to determine an appropriate dose of the candidate...

[EasyDNNnews:IfExists:Image]

[EasyDNNnews:EndIf:Image]